Kobo Biotech Ltd. Files Annual Report for FY 2024-25

Kobo Biotech Ltd. has submitted its Annual Report for the Financial Year 2024-25, as per Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company is currently under Corporate Insolvency Resolution Process (CIRP) following an application by JM Financial Asset Reconstruction Company Limited. Ms. Namrata Amol Randeri has been appointed as the Resolution Professional and is managing the company's affairs. The report includes sections on corporate information, notice of the AGM, report of the Resolution Professional, Directors' Report, secretarial and auditor's reports, and financial statements. The 32nd Annual General Meeting is scheduled for July 24, 2026, to adopt the audited financial statements.